What is Needham's price target for AERI?

Needham's latest stated price target for Aerie Pharmaceuticals Inc. (AERI) is $14, from its action on Feb 25, 2022.

What is Needham's rating on AERI?

Needham rates AERI Hold, a neutral rating, as of Aug 23, 2022.

When did Needham last change its view on AERI?

On Aug 23, 2022, Needham downgrades to Hold from Buy.

Needham AERI price target and rating history

Aerie Pharmaceuticals Inc. (AERI) · Health Care

Needham rates Aerie Pharmaceuticals Inc. (AERI) Hold with a $14 price target, as of its latest action on Aug 23, 2022. It has published 4 rating actions on AERI since August 2021, including 0 upgrades and 1 downgrade.

Current rating: Hold
Price target: $14
Median target, all firms: Too few
Actions on AERI: 4

Needham price target on AERI

Needham price target on AERI, each point a stated target, August 2021 to February 2022.

Every Needham rating on AERI

Aug 23, 2022
DowngradeNeedham downgrades to Hold from Buy
Feb 25, 2022
ReiterateNeedham cuts its price target to $14 from $22, keeps Buy
Nov 5, 2021
ReiterateNeedham cuts its price target to $22 from $24, keeps Buy
Aug 5, 2021
ReiterateNeedham cuts its price target to $24 from $26, keeps Buy

Questions about Needham and AERI

What is Needham's price target for AERI?: Needham's latest stated price target for Aerie Pharmaceuticals Inc. (AERI) is $14, from its action on Feb 25, 2022.
What is Needham's rating on AERI?: Needham rates AERI Hold, a neutral rating, as of Aug 23, 2022.
When did Needham last change its view on AERI?: On Aug 23, 2022, Needham downgrades to Hold from Buy.

All Needham ratings AERI news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.